Product image of Norvasc (Amlodipine) supplied by GNH India

Norvasc

Active Ingredient:
Amlodipine
Origin:
EU

Norvasc (Amlodipine)

Amlodipine, the active ingredient in Norvasc, is a calcium channel blocker presented as an oral tablet for oral use. It treats hypertension and angina pectoris in adult patients.
GNH India supplies Norvasc as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Upjohn Eesv

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Norvasc is a calcium channel blocker indicated for conditions affecting the cardiovascular system.

  • Hypertension: lowers elevated blood pressure and reduces cardiovascular risk.
  • Angina pectoris: decreases the frequency and severity of chest pain by improving myocardial oxygen supply.
  • Chronic stable angina: helps control symptoms during physical activity and reduces the need for short‑acting nitrates.

How It Works

  • Amlodipine selectively inhibits the influx of calcium ions through L-type calcium channels in vascular smooth muscle and cardiac myocytes. This inhibition causes arterial vasodilation, reduces peripheral vascular resistance, and modestly decreases myocardial contractility, leading to lowered blood pressure and reduced cardiac workload.

Side Effects

Amlodipine may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

  • Peripheral edema: swelling of the ankles or feet.
  • Headache: mild to moderate intensity.
  • Flushing: sensation of warmth and redness.
  • Dizziness or light‑headedness.
  • Palpitations: awareness of heartbeat.
  • Fatigue or general weakness.

Serious or Rare Side Effects

  • Severe hypotension: markedly low blood pressure.
  • Myocardial infarction: rare occurrence of heart attack.
  • Hepatic dysfunction: abnormal liver enzymes.
  • Allergic reactions: rash, pruritus, or anaphylaxis.
  • Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Blood dyscrasias: neutropenia or thrombocytopenia.

Precautions & Warnings

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for potential complications.

  • Blood pressure monitoring: check regularly, especially after dose changes.
  • Cardiovascular status: assess for heart failure or recent myocardial infarction.
  • Liver function: consider dose adjustment in severe hepatic impairment.
  • Concomitant medications: review for CYP3A4 inhibitors or other antihypertensives.
  • Pregnancy and lactation: use only if benefits outweigh potential risks.
  • Store at ambient temperature: keep below 25°C, protect from moisture and light.

Avoid Interactions

Amlodipine can interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors (e.g., clarithromycin, itraconazole): may increase amlodipine plasma levels.
  • Co‑administration with other calcium channel blockers: risk of additive hypotension.
  • Grapefruit juice: can raise systemic exposure to amlodipine.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: may enhance bradycardia or AV‑block.
  • Diuretics: may cause excessive blood pressure reduction.
  • Statins metabolized by CYP3A4 (e.g., simvastatin, atorvastatin): increased risk of statin‑related myopathy.

Frequently Asked Questions

Norvasc (amlodipine) is prescribed to manage high blood pressure (hypertension) and to relieve chest pain caused by angina pectoris. By lowering vascular resistance, it helps prevent cardiovascular complications associated with sustained hypertension and improves oxygen delivery to the heart during episodes of angina.

Amlodipine blocks L‑type calcium channels in the smooth muscle of arteries and in cardiac muscle cells. This blockade prevents calcium entry, leading to relaxation of vascular smooth muscle, arterial dilation, reduced peripheral resistance, and a modest decrease in cardiac contractility, which together lower blood pressure and lessen cardiac workload.

The appropriate dose of Norvasc is determined by the prescribing clinician based on the individual’s blood pressure, clinical response, and any co‑existing medical conditions. Dosage adjustments are made during follow‑up visits to achieve optimal therapeutic effect while minimizing adverse reactions.

The safety of amlodipine in pregnancy and lactation has not been definitively established. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the Norvasc product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Compared with other classes such as ACE inhibitors or beta‑blockers, amlodipine offers once‑daily dosing and a favorable side‑effect profile for many patients, particularly those who experience cough with ACE inhibitors. However, it may cause peripheral edema more frequently, and drug‑interaction potential differs, especially with CYP3A4‑modulating agents.

Norvasc tablets should be stored at ambient temperature, preferably below 25 °C, in the original container to protect them from moisture and light. Keep the product out of reach of children and avoid storing in humid or excessively hot environments.

Norvasc is taken orally, usually once daily, with or without food. The tablet should be swallowed whole with a glass of water. Patients should follow the dosing schedule prescribed by their healthcare provider and should not split, crush, or chew the tablet unless specifically instructed.

Serious adverse events, although rare, include severe hypotension, myocardial infarction, significant liver enzyme elevations, and severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience symptoms like fainting, chest pain, jaundice, or widespread rash.

Norvasc is contraindicated in patients with known hypersensitivity to amlodipine or any other calcium channel blocker. Caution is also advised for individuals with severe aortic stenosis, unstable angina, or recent myocardial infarction, as the drug may exacerbate these conditions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.